Form 4 for KIDS ORTHOPEDIATRICS CORP

Accepted 2022-09-22 00:00:00 ET · period of report 2022-09-20 · accession 0000899243-22-031660 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-09-22	2022-09-20	KIDS	Squadron Capital Holdings LLC	10%	X - OptEx	$0.00	+1.52M	6.90M	+28%	$0
D	2022-09-22	2022-09-20	KIDS	Squadron Capital Holdings LLC	10%	X - OptEx	$0.00	+1.52M	0	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-09-20	X	A	1,525,000	$0.00	6,901,764	D	—	—	(F2) These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC.
2	Derivative	Warrants (right to buy)	2022-09-20	X	A	1,525,000	$0.00	0	D	$0.00 · — to —	1,525,000 Common Stock	(F2) These securities are held directly by Squadron Capital LLC. Squadron Capital Holdings LLC is the controlling member of Squadron Capital LLC. (F1) Squadron Capital LLC beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants could not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. On September 19, 2022, the waiting period under the HSR Act expired. Once the warrants became exercisable, Squadron Capital LLC was obligated to exercise them within five (5) business days.